Inventor · disambiguated record
Gilles Galvani
Also filed as: GALVANI GILLES
5 granted patents·3 citations·filing 2016–2023
66Inventor score
Files withINST NAT SANTE RECH MED3ADPUERIVITAM1INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICAL INSERM1
Top patents by PatentIndex Score
5 records- 0183US11376245B2Dizocilpine derivatives as peripheral NMDA receptor antagonistsINST NAT SANTE RECH MED·Filed 2017·Granted Jul 5, 2022·3 cites·14 claims
- 0278US12274694B2Dizocilpine derivatives as peripheral NMDA receptor antagonistsINST NAT SANTE RECH MED·Filed 2023·Granted Apr 15, 2025·0 cites·8 claims
- 0368US11944616B2Dizocilpine derivatives as peripheral NMDA receptor antagonistsINSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICAL INSERM·Filed 2022·Granted Apr 2, 2024·0 cites·14 claims
- 0435US10538482B2Adamantane and memantine derivatives as peripheral NMDA receptor antagonistsINST NAT SANTE RECH MED·Filed 2016·Granted Jan 21, 2020·0 cites·16 claims
- 0526US11247982B2NMDA receptor modulators, compositions comprising same and use of these compounds in the treatment of diseases involving the central nervous systemADPUERIVITAM·Filed 2018·Granted Feb 15, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Gilles Galvani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →